← Open Payments lookup

HAKIM OGUNSANYA: Open Payments

NPI 1992166193 · MARRIOTTSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$468 in 18 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $89 · 2025 $468

Food & beverage: $468
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$126
Lundbeck LLC5$113
E.R. Squibb & Sons, L.L.C.3$60
Axsome Therapeutics, Inc.2$54
Vanda Pharmaceuticals Inc.1$40
Janssen Pharmaceuticals, Inc1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Teva Pharmaceuticals USA, Inc.1$20

Products named: INGREZZA, COBENFY, REXULTI, ABILIFY ASIMTUFII, Auvelity, FANAPT, INVEGA SUSTENNA, CAPLYTA.

Industry payments across MD — which companies pay providers there.